Your browser doesn't support javascript.
loading
Long-term outcomes of relmacabtagene autoleucel in Chinese patients with relapsed/refractory large B-cell lymphoma: Updated results of the RELIANCE study.
Ying, Zhitao; Yang, Haiyan; Guo, Ye; Li, Wenyu; Zou, Dehui; Zhou, Daobin; Wang, Zhao; Zhang, Mingzhi; Wu, Jianqiu; Liu, Hui; Wang, Chris; Ma, Laura; Yang, Su; Zhou, Zisong; Qin, Yun; Song, Yuqin; Zhu, Jun.
Afiliação
  • Ying Z; Department of Lymphoma, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University Cancer Hospital and Institute, Beijing, China.
  • Yang H; Department of Lymphoma, Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Institute of Basic Medicine and Cancer, Chinese Academy of Sciences, Hangzhou, China.
  • Guo Y; Department of Oncology, Shanghai Dongfang Hospital, Tongji University, Shanghai, China.
  • Li W; Department of Lymphoma, Guangdong Provincial People's Hospital, Guangdong Academy of Sciences, Guangzhou, China.
  • Zou D; Department of Lymphoma and Myeloma, State Key Laboratory of Experimental Hematology, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union of Medical College, Tianjin, China.
  • Zhou D; Department of Hematopathology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China.
  • Wang Z; Department of Hematopathology, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
  • Zhang M; Department of Oncology, First Affiliated Hospital, Zhengzhou University, Zhengzhou, China.
  • Wu J; Department of Medical Oncology, Jiangsu Institute of Cancer Research, Jiangsu Red Cross Cancer Center, Jiangsu Cancer Hospital, Nanjing Medical University, Nanjing, China.
  • Liu H; Department of Hematology, Beijing Hospital, Beijing, China.
  • Wang C; JW Therapeutics (Shanghai) Co, Ltd, Shanghai, China.
  • Ma L; JW Therapeutics (Shanghai) Co, Ltd, Shanghai, China.
  • Yang S; JW Therapeutics (Shanghai) Co, Ltd, Shanghai, China.
  • Zhou Z; JW Therapeutics (Shanghai) Co, Ltd, Shanghai, China.
  • Qin Y; JW Therapeutics (Shanghai) Co, Ltd, Shanghai, China.
  • Song Y; Department of Lymphoma, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University Cancer Hospital and Institute, Beijing, China. Electronic address: songyuqin@bjmu.edu.cn.
  • Zhu J; Department of Lymphoma, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University Cancer Hospital and Institute, Beijing, China. Electronic address: zhu-jun2017@outlook.com.
Cytotherapy ; 25(5): 521-529, 2023 05.
Article em En | MEDLINE | ID: mdl-36842849
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Limite: Adult / Humans País/Região como assunto: Asia Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Limite: Adult / Humans País/Região como assunto: Asia Idioma: En Ano de publicação: 2023 Tipo de documento: Article